Surgio
 
OSP
 
TDG
 

Bone Therapeutics SA : Announces all Patients Meet Primary Endpoint in ALLOB® Phase I/IIA Delayed-Union Study Interim Analysis

Bone Therapeutics SA : Announces all Patients Meet Primary Endpoint in ALLOB® Phase I/IIA Delayed-Union Study Interim Analysis
Biologics

Bone Therapeutics SA : Announces all Patients Meet Primary Endpoint in ALLOB® Phase I/IIA Delayed-Union Study Interim Analysis

Gosselies, Belgium, 20 September 2017, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces positive interim efficacy results in the Phase I/IIA delayed-union study of its allogeneic bone cell therapy product ALLOB® in 16 […]

Biogennix Bone Graft Substitute Materials Used to Treat 6000th Patient
Biologics

Biogennix Bone Graft Substitute Materials Used to Treat 6000th Patient

September 20, 2017 IRVINE, Calif.–(BUSINESS WIRE)–Irvine, California-based Biogennix, an osteobiologic company which develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, announced today that its products have now been used in more than 6000 patients. The company’s novel bone graft substitutes, osteoSPAN™ and Morpheus™ are resorbable, […]

Spine Surgeon in Thailand Successfully Completes First International Mazor Robotics PROlat™ Case
Robotics Spine Top Stories

Spine Surgeon in Thailand Successfully Completes First International Mazor Robotics PROlat™ Case

ORLANDO, Fla. – September 18, 2017 – Mazor Robotics, a pioneer and leader in the field of surgical guidance systems, announced that the first international PROlat case was performed by Assoc. Prof. Wicharn Yingsakmongkol, MD in Bangkok, Thailand. PROlat is a single-position solution for placing pedicle screws and other spinal hardware in the […]

Mazor Robotics Announces CE Mark Approval for the Mazor X Surgical Assurance Platform
Regulatory Robotics Top Stories

Mazor Robotics Announces CE Mark Approval for the Mazor X Surgical Assurance Platform

September 20, 2017 CAESAREA, Israel–(BUSINESS WIRE)–Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical robotic systems, announced today CE Mark approval for its Mazor X Surgical Assurance Platform. The CE Mark allows Mazor and its commercial partner, Medtronic, to market the Mazor […]

Stryker’s Spine Division Receives FDA Clearance for 3D-Printed Tritanium® C Anterior Cervical Cage
Regulatory Spine Top Stories

Stryker’s Spine Division Receives FDA Clearance for 3D-Printed Tritanium® C Anterior Cervical Cage

September 20, 2017 ALLENDALE, N.J.–(BUSINESS WIRE)–Stryker’s Spine division today announced that its Tritanium® C Anterior Cervical Cage, a 3D-printed interbody fusion cage intended for use in the cervical spine, has received 510(k) clearance from the U.S. Food and Drug Administration. The Tritanium C Anterior Cervical Cage is constructed from Stryker’s proprietary Tritanium […]

Band-LOK Announces Allowance for Two New U.S Patents for the Tether Clamp and Implantation System
Regulatory Top Stories

Band-LOK Announces Allowance for Two New U.S Patents for the Tether Clamp and Implantation System

CHARLOTTE, NC (PRWEB) SEPTEMBER 19, 2017 Band-LOK, LLC, an orthopedic medical device innovation firm focusing on band technologies for surgical applications, announced today that two new patents have been allowed by the USPTO on the proprietary Tether Clamp and Implantation System. Michael Albert, MD, Co-Founder of Band-LOK, said, “We continue to […]

Augmedics Secures $8.3 Million in Series A Funding for Augmented-Reality Surgical Visualization System
Financial Spine

Augmedics Secures $8.3 Million in Series A Funding for Augmented-Reality Surgical Visualization System

September 19, 2017 YOKNEAM, Israel–(BUSINESS WIRE)–Augmedics, a developer of an augmented-reality (AR) surgical visualization system, has secured $8.3 million in Series A funding. Led by Davos, Switzerland-based AO Invest, which is fully funded by the non-profit AO Foundation, as well as Israeli Innovation Authority, Terra Venture Partners and other undisclosed investors. Augmedics will […]

Centinel Spine to Acquire DePuy Synthes Prodisc Assets
Spine Top Stories

Centinel Spine to Acquire DePuy Synthes Prodisc Assets

September 19, 2017/Orthoworld Centinel Spine has entered into an agreement to purchase DePuy Synthes’ worldwide prodisc assets. The acquisition is expected to close in mid-4Q17. Terms were not disclosed. Upon completion, Centinel Spine will add cervical and lumbar artificial disc systems prodisc-C, prodisc-L, prodisc-C Vivo, prodisc-C Nova, prodisc-O and Discover […]

Bone Solutions Inc. Launches OsteoCrete® Magnesium-Based Bone Void Filler
Biologics Top Stories

Bone Solutions Inc. Launches OsteoCrete® Magnesium-Based Bone Void Filler

(PRWEB) SEPTEMBER 19, 2017 Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with bone repair and generation, and it’s the first in the U.S. to incorporate magnesium, a critical […]

Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
Biologics Top Stories

Organogenesis Names New Chief Commercial Officer and Chief Operating Officer

CANTON, Mass., Sept. 19, 2017 /PRNewswire/ — Organogenesis Inc., a commercial leader in the field of regenerative medicine with a portfolio of advanced and next-generation bioactive and acellular biomaterials products in the advanced wound care and surgical biologics markets, has elevated two industry veterans and longtime company employees, Brian Grow and Patrick Bilbo, to Chief Commercial […]

MiMedx To Host Shareholder Call On September 21, 2017 To Update Progress On Various Strategic Initiatives And Respond To Topics Requested By Shareholders
Biologics Financial

MiMedx To Host Shareholder Call On September 21, 2017 To Update Progress On Various Strategic Initiatives And Respond To Topics Requested By Shareholders

MARIETTA, Ga., Sept. 19, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today it will be hosting a webcast on Thursday, September 21, 2017 beginning at 10:30 a.m. Eastern Time to […]

MiMedx Files With The FDA To Initiate The Company’s Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee
Biologics Regulatory Top Stories

MiMedx Files With The FDA To Initiate The Company’s Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee

MARIETTA, Ga., Sept. 19, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that the Company has filed with the Food and Drug Administration (FDA) to initiate its […]